» Articles » PMID: 39040757

A Rare Case of Life-Threatening Hemorrhage

Overview
Journal Cureus
Date 2024 Jul 23
PMID 39040757
Authors
Affiliations
Soon will be listed here.
Abstract

Acquired hemophilia A is a rare but severe autoimmune bleeding disorder that results from autoantibodies against clotting factor VIII (FVIII). Distinguishing acquired hemophilia from other more common causes of bleeding, such as chronic liver disease, disseminated intravascular coagulation, or sepsis-induced coagulopathies, is crucial in guiding the management of life-threatening hemorrhage. This study describes a patient with primary biliary cholangitis who was found to have acquired hemophilia A, a unique cause of life-threatening bleeding that was especially challenging to diagnose and manage with her underlying liver disease. Identifying acquired hemophilia A allowed an avenue of treatment options that would not have otherwise been available.

References
1.
Charlebois J, Rivard G, St-Louis J . Management of acquired hemophilia A: Review of current evidence. Transfus Apher Sci. 2018; 57(6):717-720. DOI: 10.1016/j.transci.2018.10.011. View

2.
Saja M, Abdo A, Sanai F, Shaikh S, Abdel Gader A . The coagulopathy of liver disease: does vitamin K help?. Blood Coagul Fibrinolysis. 2012; 24(1):10-7. DOI: 10.1097/MBC.0b013e32835975ed. View

3.
Pishko A, Doshi B . Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice. J Blood Med. 2022; 13:255-265. PMC: 9112043. DOI: 10.2147/JBM.S284804. View

4.
Harrison M . The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting. West J Emerg Med. 2018; 19(5):863-871. PMC: 6123093. DOI: 10.5811/westjem.2018.7.37893. View

5.
Kruse-Jarres R, Kempton C, Baudo F, Collins P, Knoebl P, Leissinger C . Acquired hemophilia A: Updated review of evidence and treatment guidance. Am J Hematol. 2017; 92(7):695-705. DOI: 10.1002/ajh.24777. View